|Articles|February 1, 1997

Supplements and Featured Publications

  • Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
  • Volume 3
  • Issue 2 Suppl

Evaluating the Cost Effectiveness of Newer Psychotropic Medications

Download PDF: Evaluating the Cost Effectiveness of Newer Psychotropic Medications

Articles in this issue

about 29 years ago

Introduction: Looking Beyond the Formulary Budget

about 29 years ago

Looking Beyond the Formulary Budget in Cost-Benefit Analysis

about 29 years ago

Retrospective Analysis of the Effect of Risperidone on Clinical Outcome

about 29 years ago

Newer Antipsychotic Medications: Discussions

about 29 years ago

Bibliography

about 29 years ago

Participants

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text